Isomorphic Labs Raises $5B Series C | 2.4x Its $2.1B May Round
Isomorphic Labs raised a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining, to push its AI-designed drug candidates toward clinical trials; the company did not disclose its valuation.